Australia Structural Heart Devices Market Size & Outlook
Related Markets
Australia structural heart devices market highlights
- The Australia structural heart devices market generated a revenue of USD 162.6 million in 2023 and is expected to reach USD 514.4 million by 2030.
- The Australia market is expected to grow at a CAGR of 17.9% from 2024 to 2030.
- In terms of segment, tavr (transcatheter aortic valve replacement) was the largest revenue generating type in 2023.
- LAAC (Left Atrial Appendage Closure) is the most lucrative type segment registering the fastest growth during the forecast period.
Structural heart devices market data book summary
| Market revenue in 2023 | USD 162.6 million |
| Market revenue in 2030 | USD 514.4 million |
| Growth rate | 17.9% (CAGR from 2023 to 2030) |
| Largest segment | Tavr (transcatheter aortic valve replacement) |
| Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
| Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
Other key industry trends
- In terms of revenue, Australia accounted for 1.2% of the global structural heart devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan structural heart devices market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,712.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Structural Heart Devices Market Scope
Structural Heart Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| CardioKinetix | View profile | 11-50 | Menlo Park, California, United States, North America | http://www.cardiokinetix.com |
| Biomerics | View profile | 1001-5000 | Salt Lake City, Utah, United States, North America | http://biomerics.com |
| LivaNova PLC | View profile | 2900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | https://www.livanova.com |
| Lepu Medical | View profile | 10001+ | Changping, Beijing, China, Asia | http://en.lepumedical.com/ |
| St. Jude Medical | View profile | 10001+ | Saint Paul, Minnesota, United States, North America | http://www.sjm.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Australia structural heart devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 54.43% in 2023. Horizon Databook has segmented the Australia structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The Australian structural heart devices market is experiencing a surge, with TAVR procedures leading the charge. This minimally invasive approach is addressing a critical need in Australia, a country with a high prevalence of aortic stenosis, a condition affecting the heart's aortic valve.
Research published in BMC Health in 2021 paints a clear picture: the number of Australians aged 60 and over developing severe aortic stenosis is projected to rise significantly in the coming years. This translates to a growing demand for effective treatment options, and TAVR is stepping up to the challenge.
Moreover, Australia is committed to monitoring and improving TAVR procedures. The Transcatheter Aortic Valve Implantation Registry (TAVI-R), a collaborative effort between SAHMRI and ACOR, plays a key role. This registry meticulously tracks TAVR procedures across the country, providing valuable data on their safety, effectiveness, and potential areas for improvement.
Reasons to subscribe to Australia structural heart devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia structural heart devices market databook
-
Our clientele includes a mix of structural heart devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia structural heart devices market size, by type, 2018-2030 (US$M)
Australia Structural Heart Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
